Skip to content

Biobank Based on the i-Share Student Cohort

Biobank Based on the i-Share Student Cohort

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02568371
Acronym
bio-Share
Enrollment
1997
Registered
2015-10-05
Start date
2015-10-06
Completion date
2017-11-30
Last updated
2019-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

biobank, DNA, genetic, young adults, cohort study

Brief summary

The bio-Share project aims at collecting blood samples in students participating in the i-Share cohort (www.i-share.fr). Investigators aim at setting up a platform that will enable investigators in the future to study biological determinants of conditions that affect young adults and to test certain hypotheses on the pathophysiology and mechanisms underlying diseases occurring both at a young age and later in life (as early exposures may also impact late onset diseases)

Detailed description

The i-Share cohort was set up to study various important aspects of students' health and to better understand early mechanisms contributing to the occurrence of common diseases representing an important public health burden. The i-Share cohort is funded by an investment for the future grant from the French National Research Agency (ANR-10-COHO-05-01) with the aim to recruit 30000 students at the University of Bordeaux, and a few additional partner universities in France and abroad (www.i-share.fr). The bio-Share study is a biological repository embedded within the i-Share study, aiming at collecting blood samples (for genetic analyses as well as measurement of other biomarkers) from a subset of 2000 i-Share participants volunteering for this ancillary project. The goal is to set up a platform that will enable investigators in the future to study biological determinants of conditions that affect young adults and to test certain hypotheses on the pathophysiology and mechanisms underlying diseases occurring both at a young age and later in life (as early exposures may also impact late onset diseases). The biobank will comprise the following biological materials: plasma, serum, whole blood, red blood cells, DNA, RNA. Levels of fasting glucose and lipid levels (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides) will be returned to participants.

Interventions

None listed

Sponsors

National Research Agency, France
CollaboratorOTHER
University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be an i-Share participant in Bordeaux * Being aged 18 years or more * Being affiliated or beneficiary of a social security * Having filled out the first online i-Share questionnaire * Having signed a written informed consent

Exclusion criteria

* Pregnant or breastfeeding women, * Persons who cannot personally give their consent and adults under guardianship.

Design outcomes

Primary

MeasureTime frame
The acquisition date of blood samplesDay 1
The number of the aliquots for each of the stored biological samplesDay 1
The total volume of the aliquots for each of the stored biological samplesDay 1

Secondary

MeasureTime frame
Low-density lipoprotein-cholesterol (fasting)Day 1
Glucose (fasting)Day 1
Triglycerides (fasting)Day 1
Total cholesterol (fasting)Day 1
High-density lipoprotein cholesterol (fasting)Day 1

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026